Atopic Dermatitis Microbial Panel
To assist in the evaluation of triggers in atopic dermatitis. Fungal and bacterial infections can exacerbate AD. Staphylococcus aureus infection has been shown to maintain skin inflammation by secreting toxins known to act as 'superantigens'. S. aureus is found in > 90% of AD skin lesions and most patients with AD make specific IgE to these toxins (Enterotoxin A/B). Aggressive anti-Staphlococcal antibiotics are effective in these patients. The inflammatory response to fungi, especially Malassezia and Candida species are important triggers in AD. Treatment with anti-fungal drugs provides benefit in patients with elevated IgE to these fungi.
Proceduresee individual test information
5-7 business days from receipt of specimen
| Specimen Type | Test Code | CPT Code | NY Approved | Volume | Assay Range | Special Instructions |
|---|---|---|---|---|---|---|
| serum | 403069P | 86003 x 4 | Yes | 2 mL |
See Individual Test |
|
Specimens are approved for testing in New York only when indicated in the Specimen Information field above.
The CPT codes provided are based on Viracor Eurofins' interpretation of the American Medical Association's Current Procedural Terminology (CPT) codes and are provided for general informational purposes only. CPT coding is the sole responsibility of the billing party. Questions regarding coding should be addressed to your local Medicare carrier. Viracor Eurofins assumes no responsibility for billing errors due to reliance on the CPT codes illustrated in this material.